eFFECTOR Therapeutics, Inc. (EFTR)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue - 3.55 Million 1.43 Million 42 Million -
Cost of Revenue 22.91 Million 53 Thousand 24 Thousand 21.83 Million 307 Thousand
Gross Profit -22.91 Million 3.5 Million 1.4 Million 20.16 Million -307 Thousand
Operating Expenses 33.84 Million 32.4 Million 31.89 Million 26.18 Million 28.29 Million
Selling, General and Administrative Expenses 10.92 Million 12.64 Million 13.37 Million 4.34 Million 4.71 Million
Research and Development Expenses 22.91 Million 23.31 Million 19.95 Million 21.83 Million 23.58 Million
Other Expenses - -3.55 Million -1.43 Million 9000.00 -
Cost and Expenses 33.84 Million 32.4 Million 31.89 Million 26.18 Million 28.6 Million
Operating Income -33.84 Million -32.4 Million -31.89 Million 15.81 Million -28.6 Million
Interest Expense - 2.25 Million 1.76 Million 1.33 Million 1.38 Million
Income Tax Expense - -9.73 Million -24 Thousand 351 Thousand 135.14 Thousand
Earnings before Tax -35.81 Million -22.66 Million 15.79 Million 14.56 Million -29.73 Million
Net Income -35.81 Million -12.92 Million 15.79 Million 14.21 Million -29.73 Million
Earnings Per Share Basic -16.37 -7.85 9.78 23.74 -53.83
Earnings Per Share Diluted -16.37 -7.85 9.78 23.74 -53.83
Weighted Average Shares Outstanding 2.18 Million 1.64 Million 1.61 Million 598.55 Thousand 552.43 Thousand
Weighted Average Shares Outstanding (Diluted) 2.18 Million 1.64 Million 1.61 Million 598.55 Thousand 552.43 Thousand
Gross Margin - 0.99 0.98 0.48 -
EBIT Margin - -9.12 -22.31 0.38 -
Profit Margin - -3.64 11.05 0.34 -
EBITDA -33.73 Million -32.4 Million -31.89 Million 16.05 Million -28.29 Million
Earnings Before Tax Margin - -9.12 -22.31 0.38 -

Income Statement Charts